// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "CT CL SN BTO RIGHTS NT CLO LC WARRANTIES label USE INFORMATION PSI exclamation source name disease COULD EBI ALL ANY PRM REQUIRES DTT OPTIONAL EW ROW DJ HTML PEPTIDESEQ MS:1001251 SDRF RECOMMEND cleavage agent details DIA XML MAGE HEREIN MOD PATO HANCESTRO spiked compound SWATH PMCID SHOULD BE PP PRIDE:0000659 MHC SRM JA BMC data file STANDARDS PTM alkylation reagent DISCLAIMS organism part reduction reagent LIMITED depletion IMPLIED DOID LI URL NCBI PURPOSE fractionation method REQUIRED disease stage ISA TA instrument technical replicate collision energy PATCH PS QY source name_ and _assay name developmental stage SHALL proteomics data acquisition method sex biosample accession number CID HF MUST EFO NOT age ZFA MINOR XL VK SH CPTAC MAY HCD IDF CF PRIDE WILL MIAME fraction identifier EM CV EXPRESS III MONDO cell type UBERON PMID INFRINGE biological replicate file your VCF INCLUDING ancestry category FITNESS OR HUPO RECOMMENDED RFC BUT MT MS MERCHANTABILITY DDA PROTEOMICS replicate CS MC NCE II PARTICULAR THAT individual IAA mass pooled sample sample ID THE COLUMN BRENDA WARRANTY PO ... NOTE OF RAW CN CELL FOR URI TO ENVO TMT IS SP TAB MAJOR FDR TIP AS characteristics dissociation method INITIATIVE organism README IMPORTANT SILAC AC"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "CT CL SN BTO RIGHTS NT CLO LC WARRANTIES label USE INFORMATION PSI disease COULD EBI ALL ANY PRM REQUIRES DTT OPTIONAL EW ROW DJ HTML PEPTIDESEQ MS:1001251 SDRF RECOMMEND cleavage agent details DIA MAGE HEREIN MOD PATO HANCESTRO spiked compound SWATH PMCID SHOULD BE PP PRIDE:0000659 MHC SRM JA BMC data file STANDARDS PTM alkylation reagent DISCLAIMS organism part reduction reagent LIMITED depletion IMPLIED DOID LI URL NCBI PURPOSE fractionation method REQUIRED disease stage ISA TA instrument technical replicate collision energy PATCH PS QY SHALL proteomics data acquisition method sex biosample accession number CID HF MUST EFO NOT age ZFA MINOR XL VK SH CPTAC MAY HCD IDF CF PRIDE WILL MIAME fraction identifier EM CV EXPRESS III MONDO cell type UBERON PMID INFRINGE biological replicate VCF INCLUDING ancestry category FITNESS OR HUPO RECOMMENDED RFC BUT MT MS MERCHANTABILITY DDA PROTEOMICS CS MC NCE II PARTICULAR THAT individual IAA mass pooled sample THE COLUMN BRENDA WARRANTY PO ... OF RAW CN CELL FOR URI TO ENVO TMT IS SP TAB MAJOR FDR AS dissociation method INITIATIVE organism README SILAC AC"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005105 CL CL:0000451 MONDO:0004975 CL:0000813 UBERON:0000178 exclamation source name COVID disease UBERON:0000948 ALL UBERON:0001977 CL:0000623 UBERON:0002097 SDRF CL:0000898 xenograft CL:0000084 MONDO:0004989 DSS PATO HANCESTRO UBERON:0001359 SHOULD UBERON:0001088 PTM organism part MONDO:0004946 CL:0000540 depletion DOID PATO:0000461 MONDO:0005575 URL NCBI MONDO:0100096 NSG MONDO:0008383 MONDO:0005301 CL:0000913 CL:0000788 CSF CL:0000235 developmental stage sex MUST EFO CL:0000182 MONDO:0005148 APP CL:0000236 age compound MAY CML CL:0000057 MONDO CL:0000625 cell type CL:0000066 UBERON UBERON:0001155 enrichment process biological replicate ancestry category disease model CL:0000787 lib synthetic peptide UBERON:0002107 individual CL:0000815 ID CL:0000624 UBERON:0002048 CL:0000232 UBERON:0002113 PO UBERON:0000310 NOTE MONDO:0005180 NK CL:0000233 MONDO:0005138 PATO:0000384 CL:0000576 TIP UBERON:0001969 PDX organism IMPORTANT PATO:0000383 UBERON:0000955 PATO:0001340"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "MONDO:0005105 CL CL:0000451 MONDO:0004975 CL:0000813 UBERON:0000178 source name COVID disease UBERON:0000948 ALL UBERON:0001977 CL:0000623 UBERON:0002097 SDRF CL:0000898 xenograft CL:0000084 MONDO:0004989 DSS PATO HANCESTRO UBERON:0001359 SHOULD UBERON:0001088 PTM organism part MONDO:0004946 CL:0000540 depletion DOID PATO:0000461 MONDO:0005575 URL NCBI MONDO:0100096 NSG MONDO:0008383 MONDO:0005301 CL:0000913 CL:0000788 CSF CL:0000235 developmental stage sex MUST EFO CL:0000182 MONDO:0005148 APP CL:0000236 age compound MAY CML CL:0000057 MONDO CL:0000625 cell type CL:0000066 UBERON UBERON:0001155 enrichment process biological replicate ancestry category disease model CL:0000787 synthetic peptide UBERON:0002107 individual CL:0000815 ID CL:0000624 UBERON:0002048 CL:0000232 UBERON:0002113 PO UBERON:0000310 MONDO:0005180 NK CL:0000233 MONDO:0005138 PATO:0000384 CL:0000576 UBERON:0001969 PDX organism PATO:0000383 UBERON:0000955 PATO:0001340"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C65108 NCIT:C28077 MONDO:0004979 height PD exclamation treatment response disease NCIT:C27966 AJCC NCIT:C15262 NCIT CHEBI:41774 HANCESTRO:0009 SDRF GDPR PR HANCESTRO:0005 NCIT:C81327 NCIT:C53555 HANCESTRO NCIT:C62723 NCIT:C65107 treatment status menopausal status Ann Arbor stage TNM staging NCIT:C14169 organism part BMI NCIT:C81328 body mass index NCIT:C15313 pre-existing condition time post treatment NCIT:C28076 disease stage ethnicity diet IV prior treatment MONDO:0011122 sex PREFERRED MONDO:0004995 treatment EFO CHEBI:28748 sampling time point MONDO:0005148 medication history age gestational age NCIT:C28078 CHEBI:6801 NCI HANCESTRO:0010 III MONDO tumor grade NCIT:C15445 NCIT:C71732 NCIT:C4870 alcohol consumption ancestry category NCIT:C14167 ACE pregnancy status NCIT:C18058 NCIT:C15632 MONDO:0005300 CHEBI:27899 MONDO:0005044 NCIT:C14174 NCIT:C18213 NCIT:C53553 MONDO:0002050 smoking status NCIT:C14168 II individual NCIT:C27971 UO secondary condition dose ID weight NCIT:C18206 NCIT:C15329 HIPAA Dukes stage NCIT:C16358 HANCESTRO:0006 NCIT:C53556 NOTE NCIT:C68804 NCIT:C28079 NCIT:C65106 NCIT:C53554 ER NCIT:C27970 organism NCIT:C28054 TNM IMPORTANT compound breast cancer subtype"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C65108 NCIT:C28077 MONDO:0004979 height PD treatment response disease NCIT:C27966 AJCC NCIT:C15262 NCIT CHEBI:41774 HANCESTRO:0009 SDRF GDPR PR HANCESTRO:0005 NCIT:C81327 NCIT:C53555 HANCESTRO NCIT:C62723 NCIT:C65107 treatment status menopausal status Ann Arbor stage TNM staging NCIT:C14169 organism part BMI NCIT:C81328 body mass index NCIT:C15313 pre-existing condition time post treatment NCIT:C28076 disease stage ethnicity diet IV prior treatment MONDO:0011122 sex PREFERRED MONDO:0004995 treatment EFO CHEBI:28748 sampling time point MONDO:0005148 medication history age gestational age NCIT:C28078 CHEBI:6801 NCI HANCESTRO:0010 III MONDO tumor grade NCIT:C15445 NCIT:C71732 NCIT:C4870 alcohol consumption ancestry category NCIT:C14167 ACE pregnancy status NCIT:C18058 NCIT:C15632 MONDO:0005300 CHEBI:27899 MONDO:0005044 NCIT:C14174 NCIT:C18213 NCIT:C53553 MONDO:0002050 smoking status NCIT:C14168 II individual NCIT:C27971 UO secondary condition dose ID weight NCIT:C18206 NCIT:C15329 HIPAA Dukes stage NCIT:C16358 HANCESTRO:0006 NCIT:C53556 NCIT:C68804 NCIT:C28079 NCIT:C65106 NCIT:C53554 ER NCIT:C27970 organism NCIT:C28054 TNM compound breast cancer subtype"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "UNIMOD:21 MS:1001309 UNIMOD:1 SHOULD sample PP MS:1001917 data file ID SRM MRM CF fragment mass tolerance fraction PRIDE fraction identifier modification parameters ST ELISA LTQ NOTE NT RAW label UNIMOD:4 SCIEX scan window upper limit MGF PSI URL exclamation URI REQUIRED file uri proteomexchange accession number UNIMOD:35 instrument TA technical replicate TS MS:1001306 PRM UNIMOD TMT FTP MS1 scan range PRIDE:0000663 MSD TIP UNIMOD:737 proteomics data acquisition method MS:1001251 SDRF RECOMMENDED cleavage agent details MM scan window lower limit MT MS MUST DIA RPPA DDA HF precursor mass tolerance MOD MS2 analyzer type CS MS:1001303 IMPORTANT SILAC MS:1001313 TOF XL KR AC"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "UNIMOD:21 MS:1001309 UNIMOD:1 SHOULD PP MS:1001917 data file ID SRM MRM CF fragment mass tolerance PRIDE fraction identifier modification parameters ST ELISA LTQ NT RAW label UNIMOD:4 SCIEX scan window upper limit MGF PSI URL URI REQUIRED file uri proteomexchange accession number UNIMOD:35 instrument TA technical replicate TS MS:1001306 PRM UNIMOD TMT FTP MS1 scan range PRIDE:0000663 MSD UNIMOD:737 proteomics data acquisition method MS:1001251 SDRF RECOMMENDED cleavage agent details MM scan window lower limit MT MS MUST DIA RPPA DDA HF precursor mass tolerance MOD MS2 analyzer type CS MS:1001303 SILAC MS:1001313 TOF XL KR AC"
  }
];
